Press Releases

  • MOORESTOWN, N.J., December 19, 2018 – Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of Kevin Boesen, PharmD, as Chief Sales Officer. In his new role, Dr. Boesen will be responsible for all direct and channel sales efforts in the United States and Canada, with a focus on expanding the adoption of TRHC’s signature product, MedWise™, into health plans, healthcare systems, Programs
  • MOORESTOWN, N.J., December 03, 2018 — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced it has executed a definitive agreement to acquire Brisbane, Australia based DoseMe. DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes. Already available
  • MOORESTOWN, N.J., November 08, 2018 — Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, recently completed the acquisition of healthcare technology company, Cognify. Founded in San Francisco in 1998, Cognify is focused on enabling patient-centered, multidisciplinary, coordinated and integrated care along with financial management for the federal Program of All-inclusive Care for the Elderly (PACE) as well as Managed Long-term Care (MLTC) and medical home providers. Cognify’s
  • MOORESTOWN, N.J., November 08, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Landmark Health (“Landmark”), an industry leader of in-home, risk-based medical care, today announced an expansion of a pilot program using MedWise™, a proprietary software designed to identify medication risk and prevent drug-related adverse outcomes. A phase I pilot study was designed to compare healthcare resource utilization and costs between a control
  • Moorestown, NJ (November 5, 2018) – Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, appointed Kathrine O’Brien to its Board of Directors. The appointment occurred at TRHC’s meeting of the Board of Directors held on November 2, 2018 and was effective immediately. Ms. O’Brien is a recognized consumer packaged goods (CPG) executive with 30 years of experience. Most recently, she served as Vice President/General Manager for Skin
  • MOORESTOWN, N.J., Nov. 01, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, applauds the signing into law of the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment) for Patients and Communities Act. One of the major policy changes in the new law, which became effective upon signing, will require Medicare Part D plan sponsors to adopt Medication Therapy Management (MTM) programs for
  • MOORESTOWN, N.J. and COLORADO SPRINGS, Colo., Oct. 30, 2018 — Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced that TRHC subsidary CareKinesis® has begun to provide its comprehensive PACE medication risk management services to Rocky Mountain PACE, a program of Rocky Mountain Health Care Services (RMHCS), based in Colorado Springs, CO. PACE is the
  • MOORESTOWN, N.J., Oct. 23, 2018 — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its third quarter 2018 operating results on Tuesday, November 6, 2018 after market close, on the investor relations section of TRHC’s website at ir.trhc.com with a conference call hosted by Chairman and CEO, Calvin H. Knowlton, Ph.D., President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA, and Chief
  • MOORESTOWN, N.J., Oct. 22, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, is participating in the 2018 NPA (National PACE Association) conference being held in Portland, OR, October 21-24, 2018. “The NPA Annual Conference is a great opportunity for us to spend time with our PACE clients from around the country,” stated TRHC President Orsula V. Knowlton, PharmD, MBA. “We educate, we learn, we
  • MOORESTOWN, N.J., Oct. 22, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the launch of CareVention HealthCare, a comprehensive technology and consulting services division. CareVention, which represents the idea of care innovation and intervention to optimize health outcomes, aims to improve the integration of TRHC’s subsidiary brands and industry-proven technology products for an enhanced client experience. “We see an opportunity to deliver